PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2024-02-08

Date Title Company
08-Feb-2024 Celebrating Its Fifth Anniversary, Genesis Reference Laboratories Announces Testing Upgrades AccessWire
08-Feb-2024 Dr. Michael Jewett Joins Theralase(R) to Help Complete Enrollment in the Phase II Non-Muscle Invasive Bladder Cancer Clinical Study AccessWire
08-Feb-2024 AmplifyBio CEO J. Kelly Ganjei Discusses Solutions for Reducing Costs and Risk in Advanced Therapy Manufacturing During Fireside Chat at Advanced Therapies Week AccessWire
08-Feb-2024 Zomedica Announces Sponsorship of Educational Presentations at Major Veterinary Health Conferences AccessWire
08-Feb-2024 Planet 13 Announces Expansion of Leadership Team and Board AccessWire
08-Feb-2024 ZOLL One of the First to Receive Approval for AEDs Under the EU Medical Device Regulation (MDR) Certification Businesswire
08-Feb-2024 Theriva Biologics Announces Positive Recommendation from the Independent Data Monitoring Committee of VIRAGE, the Phase 2b Clinical Trial of VCN-01 in Combination with Chemotherapy for Metastatic Pancreatic Ductal Adenocarcinoma Theriva Biologics
08-Feb-2024 Spexis announces closing of sale of preclinical antibiotics program to Basilea Spexis
08-Feb-2024 AI may automate diagnosis of lupus nephritis, says GlobalData GlobalData
08-Feb-2024 Orexa Announces First Patient Dosed in Phase 2 Trial in Post-Operative Patients Orexa B.V.
08-Feb-2024 Vandria Awarded €3.8M in Prestigious Innosuisse and Eurostars Grants to Advance Innovative Drug Programs for Age-Related Diseases of the CNS and Muscle Vandria
08-Feb-2024 ELRIG UK Announces Steve Bates and Dr Anderson Ryan as Keynote Speakers at Research and Innovation 2024 ELRIG UK
08-Feb-2024 Zetta Genomics expands second seed funding round with additional £1.8 million Zetta Genomics
08-Feb-2024 OGT expands NGS operations to state-of-the-art facility in Oxford Technology Park OGT
08-Feb-2024 Researchers identify potential way to treat genetic epilepsy by replacing ‘lost’ enzyme Francis Crick Institute
08-Feb-2024 GenSight Biologics announces completion of a €5 million capital increase with Sofinnova Partners, Invus, UPMC Enterprises and Heights Capital Businesswire
08-Feb-2024 Global Psoriatic Arthritis (PsA) Treatment Market to achieve a remarkable US$ 15.6 Billion by 2028, fueled by advancements and patient-focused approaches | FMI MARKITWIRED
08-Feb-2024 Global Onychomycosis Treatment Market is poised for substantial growth, aiming to hit US$ 10,608.8 million by 2033 | FMI MARKITWIRED
08-Feb-2024 Explosive Growth Predicted for Therapeutic Nuclear Medicines Market is projected to increase US$ 1.84 Billion by 2028 | FMI MARKITWIRED
08-Feb-2024 Global Bioimpedance Devices Market Predicted to Surge, Reaching US$ 715.1 Million by 2028 | FMI MARKITWIRED